First US state Rx cover for seniors, disabled

3 April 2001

Massachussetts is the first US state to provide all senior citizens anddisabled people with prescription drug coverage. The Massachussetts Prescription Advantage Plan covers all senior residents of the state aged 65 and over, regardless of income, and people with disabilities whose income is at or below 188% of the poverty line.

The plan also guarantees that no participant will spend more than 10% or $2,000, whichever is less, of their annual income on prescription drugs, and guarantees access to all pharmaceuticals.

Teresa Heinz, chairwoman of the Heinz Family Philanthropies, initiated the development of the HOPE Plan (Heinz plan to Overcome Prescription drug Expenses), the original blueprint recommending that all people aged 65 and over should have access to affordable prescription drug coverage. Massachussetts' State House and Senate passed different versions of the HOPE Plan, but both did so unanimously, and Governor Cellucci included it as part of the fiscal 2001 budget.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight